Evaluation of the predictive role of standard laboratory tests for disease severity in patients with deep venous thrombosis
Introduction: Deep venous thrombosis (DVT) can result in fatal outcomes if it is not timely
diagnosed and sufficiently treated. Some laboratory markers were identified in previous …
diagnosed and sufficiently treated. Some laboratory markers were identified in previous …
New perspectives for prevention of the post-thrombotic syndrome
P Prandoni - Bleeding, Thrombosis and Vascular Biology, 2022 - btvb.org
While on conventional anticoagulation, up to 50% of patients with one or more episodes of
proximal deep vein thrombosis (DVT) can develop post-thrombotic (PTS) manifestations …
proximal deep vein thrombosis (DVT) can develop post-thrombotic (PTS) manifestations …
益气活血方联合肝素钠注射液治疗急性下肢深静脉血栓临床观察
杨静， 王峰， 王植荣， 于巧亚， 马洪皓， 马静 - 现代中医临床, 2022 - xblc.bucm.edu.cn
目的观察益气活血方联合肝素钠注射液治疗急性下肢深静脉血栓的临床疗效. 方法将70
例急性下肢深静脉血栓气虚血瘀证患者随机分为治疗组35 例, 治疗组35 例, 剔除脱落病例后 …
例急性下肢深静脉血栓气虚血瘀证患者随机分为治疗组35 例, 治疗组35 例, 剔除脱落病例后 …
[PDF][PDF] Expression of P-selectin, VCAM-1, and PSGL-1 in traumatic deep venous thrombosis
J Mo, D Zhang, R Yang - Int. J. Clin. Exp. Pathol, 2016 - e-century.us
The morbidity and mortality of traumatic deep vein thrombosis (DVT) show an increasing
trend year by year. This research observed thrombosis by establishing rat DVT model and …
trend year by year. This research observed thrombosis by establishing rat DVT model and …
Impaired plasminogen binding in patients with venous thromboembolism: association with protein carbonylation
J Siudut, J Natorska, M Zabczyk, D Zajac… - Thrombosis …, 2018 - Elsevier
Introduction Venous thromboembolism (VTE) is associated with hypofibrinolysis. Its
mechanisms are poorly understood. We investigated plasminogen-fibrin interaction and its …
mechanisms are poorly understood. We investigated plasminogen-fibrin interaction and its …
Briefing Therapeutic Approaches in Anticoagulant, Thrombolytic, and Antiplatelet Therapy
Abnormal blood clotting disorders (hypercoagulable states) are the leading causes of
mortality and morbidity in many of developing and developed countries. Hypercoagulable …
mortality and morbidity in many of developing and developed countries. Hypercoagulable …
[HTML][HTML] Protocol: MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial
JP Galanaud, J Abdulrehman, A Lazo-Langner… - BMJ Open, 2021 - ncbi.nlm.nih.gov
Introduction After deep vein thrombosis, up to 50% of patients develop post-thrombotic
syndrome (PTS). PTS is a chronic condition that reduces quality of life (QOL). Cornerstones …
syndrome (PTS). PTS is a chronic condition that reduces quality of life (QOL). Cornerstones …
Развитие посттромботической болезни на фоне пролонгированной антитромботической терапии с учетом содержания маркеров воспаления, гемостаза и …
АС Петриков, ДВ Дудин, ЛН Попкова - Флебология, 2020 - elibrary.ru
Представляет интерес изучение связей между содержанием маркеров воспаления,
гемостаза и эндотелиальной дисфункции (ЭД) и формированием клинических …
гемостаза и эндотелиальной дисфункции (ЭД) и формированием клинических …
[HTML][HTML] Clinical and radiological outcomes of adjuvant catheter-directed thrombolysis of acute iliofemoral venous thrombosis compared to standard anticoagulant …
YM Alkhateep, A Fareed… - The Egyptian Journal of …, 2023 - journals.lww.com
Background For many years, in the open vein hypothesis, it has been assumed that rapid
thrombus elimination and restoration of unobstructed deep venous flow may prevent …
thrombus elimination and restoration of unobstructed deep venous flow may prevent …
Postthrombotic Syndrome
JP Galanaud, SR Kahn - Consultative Hemostasis and Thrombosis, 2019 - Elsevier
Postthrombotic syndrome (PTS) is the most frequent complication of deep vein thrombosis
(DVT). After a proximal DVT, 20% to 50% of patients will develop PTS and 5% to 10% of …
(DVT). After a proximal DVT, 20% to 50% of patients will develop PTS and 5% to 10% of …